Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Oral Dosage Form ×

Regulatory Updates

Sep 19, 2026•1 min read

FDA Approves ANDA077968 for Alprazolam Extended‑Release Tablets (IMPAX Labs)

The FDA approved ANDA077968 on May 24, 2007 for IMPAX Labs' oral extended‑release alprazolam tablets, all listed as discontinued products.